AI In Pharma Global Market Report 2025

AI In Pharma Global Market Report 2025 – By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule, Large Molecules), By Application (Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction) – Market Size, Trends, And Global Forecast 2025-2034

Name: AI In Pharma Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

AI In Pharma Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

AI In Pharma Market Definition

AI in pharma refers to the use of automated algorithms for jobs that normally need human intelligence. Large datasets including disease patterns can be successfully identified by AI solutions in pharma, and they can also assist in understanding which medication formulations would be most effective for treating certain ailments.

The artificial intelligence (AI) in the pharma market covered in the report is segmented by technology into context-aware processing, natural language processing, querying method, and deep learning and by drug type into small molecule, and large molecules, by application into diagnosis, clinical trial research, drug discovery, research and development, epidemic prediction.

AI In Pharma Market Segmentation

The AI in pharma market covered in this report is segmented –

1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

2) By Drug Type: Small Molecule, Large Molecules

3) By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction

Subsegments:

1) By Context-Aware Processing: Real-Time Data Processing, Contextual Recommendation Systems, Adaptive Learning Systems

2) By Natural Language Processing (NLP): Text Analytics And Sentiment Analysis, Chatbots And Virtual Assistants, Document And Data Mining

3) By Querying Method: Structured Querying, Unstructured Querying, Semantic Search Technologies

4) By Deep Learning: Neural Networks For Drug Discovery, Image Recognition For Medical Imaging, Predictive Analytics Models

AI In Pharma Market Size and growth rate 2025 to 2029: Graph

AI In Pharma Market Size 2025 And Growth Rate

The AI in pharma market size has grown exponentially in recent years. It will grow from $2.92 billion in 2024 to $3.8 billion in 2025 at a compound annual growth rate (CAGR) of 30.1%. The growth in the historic period can be attributed to increased adoption of artificial intelligence (AI) for cost efficient drug discovery and rising implementation of AI in radiology.

AI In Pharma Market Growth Forecast

The AI in pharma market size is expected to see exponential growth in the next few years. It will grow to $9.64 billion in 2029 at a compound annual growth rate (CAGR) of 26.2%. The growth in the forecast period can be attributed to adoption of cloud-based applications and services by pharma companies, increasing healthcare expenditure and growing government support rising to AI development. Major trends in the forecast period include introduction of generative AI in pharma, use of AI in molecular target identification, integration of AI in drug screening process, advancements in AI tools for the pharmaceutical industry, growing investments to develop new product solutions and strategic partnerships and collaborations among market players.

Book your 30 minutes free consultation with our research experts

AI In Pharma Market Driver: Government Backing Fuels Growth Of AI In Pharma Market With Financial Programs And Research Initiatives

The growing government support for AI development is expected to propel the growth of the AI in pharma market going forward. Governments recognize the potential of AI technologies in revolutionizing the pharma sector and they are increasingly implementing policies and initiatives to promote their adoption. Many countries have developed national AI strategies that include a focus on healthcare and pharmaceutical applications. These strategies aim to stimulate the development and utilization of AI technology to promote scientific development and solve real problems in the country. For example, in April 2022, the Australian government announced a financing program worth AUD44 million ($29.61 million) to support AI research among small and medium-sized enterprises (SMEs). This initiative is part of a broader strategy to increase the application of AI in Australia's national manufacturing priority sectors and digital growth priority areas, which include the pharmaceutical industry. The funding will be used to establish digital capability centers, which will serve as hubs for AI research and development. These centers will provide resources, training, and support to SMEs, helping them to develop and implement AI technologies. Therefore, the growing government support will drive the growth of the AI in pharma market during the forecast period.

AI In Pharma Market Driver: Cloud-Based Drug Discovery Platforms Propel AI Adoption In Pharma For Enhanced Research And Collaboration

The rising adoption of cloud-based applications and services by pharmaceutical companies is expected to propel the growth of the AI in pharma market going forward. Cloud-based drug discovery platforms are a cutting-edge method of conducting research and development in the pharmaceutical industry. They leverage data analytics and cloud computing technologies to enhance drug discovery procedures, offering a wide range of tools and functionalities necessary for different facets of drug research and discovery. These platforms improve the efficiency, economy, and collaboration of the processes. Pharmaceutical companies are significant market participants and end-users of these platforms, which help these companies handle large amounts of clinical, chemical, and biological data by providing secure data storage options. For instance, in December 2023, according to Eurostat Statistics, a Luxembourg-based provider of statistical information and analysis, 2023, 45.2% of European Union enterprises used cloud computing, up 4.2 percentage points from 2021. Most utilize IT for email hosting, file storage, and office software. Additionally, 75.3% adopted advanced cloud services for security applications, database hosting, and application development platforms, reflecting a growing reliance on digital solutions for improved efficiency and security. Therefore, the increasing adoption of cloud-based applications and services by pharmaceutical companies will drive the AI in pharma market growth during the forecast period.

Global AI In Pharma Market Major Players

Major companies operating in the AI in pharma market include Concerto HealthAI, Alphabet Inc., OWKIN, Nvidia Corporation, PathAI, Insilico Medicine, Exscientia, Microsoft Corporation, XtalPi, Intel, Standigm, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., China National Pharmaceutical Group Co. Ltd. (Sinopharm), Jiangsu Hengrui Medicine Co. Ltd, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharma, Alliance Pharm Pte Ltd., Shanghai Pharmaceuticals, DeepMind, GlaxoSmithKline, Sanofi, Bayer, Renalytix AI, Merck, AstraZeneca, Iktos, Benevolent AI, Novartis, Ardigen, Botkin, Webiomed, Care Mentor AI, Diagnocat, IBM Corporation, Atomwise Inc., Cloud Pharmaceuticals, Bioage, NuMedii, Envisagenics, Aria Pharmaceuticals, Verge Genomics, Berg LLC, Cyclica, IQVIA, Roche, Pfizer, PRA Health Science, Gesto, Intensicare, Epitrack, Deep Genomics Inc., Welltok Inc., Oncora Medical, Recursion Pharmaceuticals Inc., Nucleai, Pepticom, Rology, hearX Group, DilenyTech, iNNOHEALTH Technology Solutions

Global AI In Pharma Market Trend: Introduction Of Advanced AI Tools By Pharma Companies Marks A Pivotal Trend In The Industry

Companies operating in the AI for the pharma market are introducing new AI tools that will be beneficial for the pharma companies and this is a key trend in AI in the pharma market. AI helps in quality control, predictive maintenance, waste reduction, design optimization, and process automation. For instance, in August 2022, Sanford Health, a US-based non-profit, integrated healthcare delivery system, and Sharp HealthCare, a US-based non-profit organization in healthcare partnered with Dandelion Health, a US-based healthcare artificial intelligence (AI) company, introduced a comprehensive data platform that gives health institutions access to high-quality, representative patient data for clinical AI development. The Dandelion Platform is made to give health AI developers secure, ethical access to patient datasets which include images, waveforms, and structured health records, so they may make tools and products that will help patients and clinicians.

Global AI In Pharma Market Trend: Companies Embrace Generative AI In Pharma To Enhance Patient Interactions And Record Management

Companies in the market are increasingly focusing on using generative AI in pharma to improve medical consultations. Generative AI, a subfield of artificial intelligence that focuses on creating new data instances that resemble existing data, has been introduced into the pharmaceutical industry with the potential to revolutionize drug discovery and development and medical records management. For example, in October 2023, Ubie, a Japan-based medical AI startup, introduced a new Generative AI feature for doctors that streamlines medical record documentation and summarizes patient findings. This feature, known as the'Medical Interview Summary Function,' uses a Large Language Model (LLM) to generate AI-based summaries from patient visits, specifically summarizing the 20-30 questions related to symptoms and lifestyle habits that patients answer on the'Ubie Medical Navi' product. The LLM presents this summary on the doctor's PC screen, allowing doctors to quickly understand the patient's symptoms and concerns, thereby improving the quality of medical consultations.

AI In Pharma Market Merger And Acquisition: BioNTech Strengthens AI-Driven Drug Discovery With InstaDeep Acquisition

In July 2023, BioNTech SE, a Germany-based biotechnology company that develops and manufactures active immunotherapies, acquired InstaDeep for an undisclosed amount. The acquisition aims to enhance BioNTech’s AI-driven drug discovery and development capabilities, accelerating the creation of next-generation immunotherapies and vaccines. InstaDeep is a UK-based technology company specializing in artificial intelligence (AI) and machine learning (ML) solutions.

Regional Outlook For The Global AI In Pharma Market

North America was the largest region in the AI in pharma market in 2024. The regions covered in the AI in pharma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the AI in pharma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the AI In Pharma Market?

The AI in the pharma market includes revenues earned by entities by implementing quality control, addressing supply chain problems in the production line, and minimizing material waste. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the AI In Pharma Industry?

The artificial intelligence (AI) in pharma market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in pharma market statistics, including artificial intelligence (AI) in pharma industry global market size, regional shares, competitors with artificial intelligence (AI) in pharma market share, detailed artificial intelligence (AI) in pharma market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in pharma industry. This artificial intelligence (AI) in pharma market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

AI In Pharma Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$3.8 billion
Revenue Forecast In 2034	$9.64 billion
Growth Rate	CAGR of 26.2% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning 2) By Drug Type: Small Molecule, Large Molecules 3) By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction Subsegments: 1) By Context-Aware Processing: Real-Time Data Processing, Contextual Recommendation Systems, Adaptive Learning Systems 2) By Natural Language Processing (NLP): Text Analytics And Sentiment Analysis, Chatbots And Virtual Assistants, Document And Data Mining 3) By Querying Method: Structured Querying, Unstructured Querying, Semantic Search Technologies 4) By Deep Learning: Neural Networks For Drug Discovery, Image Recognition For Medical Imaging, Predictive Analytics Models
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Concerto HealthAI, Alphabet Inc., OWKIN, Nvidia Corporation, PathAI, Insilico Medicine, Exscientia, Microsoft Corporation, XtalPi, Intel, Standigm, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., China National Pharmaceutical Group Co. Ltd. (Sinopharm), Jiangsu Hengrui Medicine Co. Ltd, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharma, Alliance Pharm Pte Ltd., Shanghai Pharmaceuticals, DeepMind, GlaxoSmithKline, Sanofi, Bayer, Renalytix AI, Merck, AstraZeneca, Iktos, Benevolent AI, Novartis, Ardigen, Botkin, Webiomed, Care Mentor AI, Diagnocat, IBM Corporation, Atomwise Inc., Cloud Pharmaceuticals, Bioage, NuMedii, Envisagenics, Aria Pharmaceuticals, Verge Genomics, Berg LLC, Cyclica, IQVIA, Roche, Pfizer, PRA Health Science, Gesto, Intensicare, Epitrack, Deep Genomics Inc., Welltok Inc., Oncora Medical, Recursion Pharmaceuticals Inc., Nucleai, Pepticom, Rology, hearX Group, DilenyTech, iNNOHEALTH Technology Solutions
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. AI In Pharma Market Characteristics

3. AI In Pharma Market Trends And Strategies

4. AI In Pharma Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global AI In Pharma Growth Analysis And Strategic Analysis Framework

5.1. Global AI In Pharma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global AI In Pharma Market Growth Rate Analysis

5.4. Global AI In Pharma Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global AI In Pharma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global AI In Pharma Total Addressable Market (TAM)

6. AI In Pharma Market Segmentation

6.1. Global AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Context-Aware Processing

Natural Language Processing

Querying Method

Deep Learning

6.2. Global AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Small Molecule

Large Molecules

6.3. Global AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnosis

Clinical Trial Research

Drug Discovery

Research and Development

Epidemic Prediction

6.4. Global AI In Pharma Market, Sub-Segmentation Of Context-Aware Processing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Real-Time Data Processing

Contextual Recommendation Systems

Adaptive Learning Systems

6.5. Global AI In Pharma Market, Sub-Segmentation Of Natural Language Processing (NLP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Text Analytics And Sentiment Analysis

Chatbots And Virtual Assistants

Document And Data Mining

6.6. Global AI In Pharma Market, Sub-Segmentation Of Querying Method, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Structured Querying

Unstructured Querying

Semantic Search Technologies

6.7. Global AI In Pharma Market, Sub-Segmentation Of Deep Learning, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Neural Networks For Drug Discovery

Image Recognition For Medical Imaging

Predictive Analytics Models

7. AI In Pharma Market Regional And Country Analysis

7.1. Global AI In Pharma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global AI In Pharma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific AI In Pharma Market

8.1. Asia-Pacific AI In Pharma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China AI In Pharma Market

9.1. China AI In Pharma Market Overview

9.2. China AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India AI In Pharma Market

10.1. India AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan AI In Pharma Market

11.1. Japan AI In Pharma Market Overview

11.2. Japan AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia AI In Pharma Market

12.1. Australia AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia AI In Pharma Market

13.1. Indonesia AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea AI In Pharma Market

14.1. South Korea AI In Pharma Market Overview

14.2. South Korea AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe AI In Pharma Market

15.1. Western Europe AI In Pharma Market Overview

15.2. Western Europe AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK AI In Pharma Market

16.1. UK AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany AI In Pharma Market

17.1. Germany AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France AI In Pharma Market

18.1. France AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy AI In Pharma Market

19.1. Italy AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain AI In Pharma Market

20.1. Spain AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe AI In Pharma Market

21.1. Eastern Europe AI In Pharma Market Overview

21.2. Eastern Europe AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia AI In Pharma Market

22.1. Russia AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America AI In Pharma Market

23.1. North America AI In Pharma Market Overview

23.2. North America AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA AI In Pharma Market

24.1. USA AI In Pharma Market Overview

24.2. USA AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada AI In Pharma Market

25.1. Canada AI In Pharma Market Overview

25.2. Canada AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America AI In Pharma Market

26.1. South America AI In Pharma Market Overview

26.2. South America AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil AI In Pharma Market

27.1. Brazil AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East AI In Pharma Market

28.1. Middle East AI In Pharma Market Overview

28.2. Middle East AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa AI In Pharma Market

29.1. Africa AI In Pharma Market Overview

29.2. Africa AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. AI In Pharma Market Competitive Landscape And Company Profiles

30.1. AI In Pharma Market Competitive Landscape

30.2. AI In Pharma Market Company Profiles

30.2.1. Concerto HealthAI Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Alphabet Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. OWKIN Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Nvidia Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.5. PathAI Overview, Products and Services, Strategy and Financial Analysis

31. AI In Pharma Market Other Major And Innovative Companies

31.1. Insilico Medicine

31.2. Exscientia

31.3. Microsoft Corporation

31.4. XtalPi

31.5. Intel

31.6. Standigm

31.7. Takeda Pharmaceutical Company Ltd.

31.8. Otsuka Pharmaceutical Co. Ltd.

31.9. China National Pharmaceutical Group Co. Ltd. (Sinopharm)

31.10. Jiangsu Hengrui Medicine Co. Ltd

31.11. Cipla Limited

31.12. Aurobindo Pharma Limited

31.13. Dr. Reddy’s Laboratories Ltd.

31.14. Sun Pharma

31.15. Alliance Pharm Pte Ltd.

32. Global AI In Pharma Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI In Pharma Market

34. Recent Developments In The AI In Pharma Market

35. AI In Pharma Market High Potential Countries, Segments and Strategies

35.1 AI In Pharma Market In 2029 - Countries Offering Most New Opportunities

35.2 AI In Pharma Market In 2029 - Segments Offering Most New Opportunities

35.3 AI In Pharma Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global AI In Pharma Market, Sub-Segmentation Of Context-Aware Processing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global AI In Pharma Market, Sub-Segmentation Of Natural Language Processing (NLP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global AI In Pharma Market, Sub-Segmentation Of Querying Method, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global AI In Pharma Market, Sub-Segmentation Of Deep Learning, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global AI In Pharma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global AI In Pharma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Concerto HealthAI Financial Performance

Table 79: Alphabet Inc. Financial Performance

Table 80: OWKIN Financial Performance

Table 81: Nvidia Corporation Financial Performance

Table 82: PathAI Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global AI In Pharma Market, Sub-Segmentation Of Context-Aware Processing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global AI In Pharma Market, Sub-Segmentation Of Natural Language Processing (NLP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global AI In Pharma Market, Sub-Segmentation Of Querying Method, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global AI In Pharma Market, Sub-Segmentation Of Deep Learning, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global AI In Pharma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global AI In Pharma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, AI In Pharma Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, AI In Pharma Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, AI In Pharma Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Concerto HealthAI Financial Performance

Figure 79: Alphabet Inc. Financial Performance

Figure 80: OWKIN Financial Performance

Figure 81: Nvidia Corporation Financial Performance

Figure 82: PathAI Financial Performance

Opportunities And Strategies Analysis For The Automotive V2X Market – Includes Automotive V2X Market Share

Global Product Lifecycle Management Market Opportunities And Strategies – Forecast To 2030 – Includes Product Lifecycle Management Market Size

Global Session Initiation Protocol SIP Trunking Services Market Opportunities And Strategies – Forecast To 2030 – Includes Session Initiation Protocol (SIP) Trunking Services Market Overview

Insights On The Artificial Intelligence In Healthcare Market Size And Growth Rate – Includes Artificial Intelligence In Healthcare Market Size

The Business Research Company offers the open source intelligence market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the projection mapping market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the soc as a service market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the employment screening services market research report 2022 with industry size, share, segments and market growth

Big Data and Analytics Global Market Report 2025 – By Analytics Tools (Dashboard & Data Visualization, Self-Service Tools, Data Mining & Warehousing, Reporting , Other Analytics Tools), By Deployment Mode (On-Premise, Cloud), By Application (Customer Analytics, Supply Chain Analytics, Marketing Analytics, Pricing Analytics, Spatial Analytics, Workforce Analytics, Risk & Credit Analytics , Transportation Analytics, Other Applications), By End Use Industry (BFSI, Retail, Manufacturing, IT and Telecom, Government, Healthcare, Utility, Other End Use Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical API Manufacturing Global Market Report 2025 – By Therapy Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, Other Therapeutics Uses), By API Type (Chemical API, Biological API), By Drug Type (Prescription Drugs, Over-The-Counter (OTC) Drugs) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharma Microbiology Testing Kits Global Market Report 2025 – By Product (Consumables, Equipment), By Test (Endotoxin Testing, Sterility Testing, Microbial Examination, Environmental Monitoring, Other Tests), By End User (Hospitals & Diagnostic Centers, Custom Lab Service Providers, Academic & Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmacies and Healthcare Stores Global Market Report 2025 – By Type (Pharmacies And Drug Stores, Food (Health) Supplement Stores, Other Healthcare And Personal Care Stores), By Ownership (Retail Chain, Independent Stores), By drug type (Prescription Drugs, Over-The-Counter (OTC) Drugs) – Market Size, Trends, And Global Forecast 2025-2034

View Report

IoT Global Market Report 2025 – By Platform (Device Management, Application Management, Network Management), By Application (Building And Home Automation, Smart Energy And Utilities, Smart Manufacturing, Connected Logistics, Smart Retail, Smart Mobility And Transportation, Other Applications), By End Use Industry (BFSI, Retail, Government, Healthcare, Manufacturing, Transportation, IT & Telecom, Other End-User Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Artificial Intelligence Global Market Report 2025 – By Offering (Hardware, Software, Services), By Technology (Machine learning, Natural language processing, Context-Aware Computing, Computer Vision, Other Technologies (Image processing, Speech recognition)), By End-user Industry (Healthcare, Automotive, Agriculture, Retail, Marketing, Telecommunication, Defense, Aerospace, Media & Entertainment, Other End-User Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Artificial Intelligence Services Global Market Report 2025 – By Technology (Machine Learning, Computer Vision, Natural Language Processing (NLP), Other Technology), By Services Type (Managed Services, Professional Services), By Software Tools (Web-based and Cloud Application Programming Interface, Processing and Modeler, Archiving and Data Storage), By Application Type (Fraud Detection, Data Analytics & Visualization, Customer Service and Management, Risk Management, Compliance & Security), By End-User (Banking, Financial, and Insurance (BFSI), IT & Telecom, Retail, Manufacturing, Public Sector, Energy & Utility, Healthcare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Information Technology Global Market Report 2025 – By Type (IT Services, Computer Hardware, Telecom, Software Products), By Organization Size (Large Enterprise, Small and Medium Enterprise), By End User (Financial Services, Retail & Wholesale, Manufacturing, Healthcare, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the AI In Pharma market?

How will the AI In Pharma market drivers and restraints affect the market dynamics? What forces will shape the AI In Pharma industry going forward?

The AI In Pharma market major growth driver - Government Backing Fuels Growth Of AI In Pharma Market With Financial Programs And Research Initiatives. For further insights on the AI In Pharma market, request a sample here

What is the forecast market size or the forecast market value of the AI In Pharma market?

The AI In Pharma market size has grown strongly in recent years. The AI in pharma market size has grown exponentially in recent years. It will grow from $2.92 billion in 2024 to $3.8 billion in 2025 at a compound annual growth rate (CAGR) of 30.1%. The growth in the historic period can be attributed to increased adoption of artificial intelligence (AI) for cost efficient drug discovery and rising implementation of AI in radiology. The AI in pharma market size is expected to see exponential growth in the next few years. It will grow to $9.64 billion in 2029 at a compound annual growth rate (CAGR) of 26.2%. The growth in the forecast period can be attributed to adoption of cloud-based applications and services by pharma companies, increasing healthcare expenditure and growing government support rising to AI development. Major trends in the forecast period include introduction of generative AI in pharma, use of AI in molecular target identification, integration of AI in drug screening process, advancements in AI tools for the pharmaceutical industry, growing investments to develop new product solutions and strategic partnerships and collaborations among market players. For further insights on the AI In Pharma market, request a sample here

How is the AI In Pharma market segmented?

The AI in pharma market covered in this report is segmented –
1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning
2) By Drug Type: Small Molecule, Large Molecules
3) By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction Subsegments:
1) By Context-Aware Processing: Real-Time Data Processing, Contextual Recommendation Systems, Adaptive Learning Systems
2) By Natural Language Processing (NLP): Text Analytics And Sentiment Analysis, Chatbots And Virtual Assistants, Document And Data Mining
3) By Querying Method: Structured Querying, Unstructured Querying, Semantic Search Technologies
4) By Deep Learning: Neural Networks For Drug Discovery, Image Recognition For Medical Imaging, Predictive Analytics Models For further insights on the AI In Pharma market, request a sample here

Which region has the largest share of the AI In Pharma market? What are the other regions covered in the report?

North America was the largest region in the AI in pharma market in 2024. The regions covered in the AI in pharma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the AI In Pharma market, request a sample here.

Who are the major players in the AI In Pharma market?

What are the key trends in the AI In Pharma market?

Major trends in the AI In Pharma market include Introduction Of Advanced AI Tools By Pharma Companies Marks A Pivotal Trend In The Industry. For further insights on the AI In Pharma market, request a sample here.

What are the major opportunities in the AI In Pharma market? What are the strategies for the AI In Pharma market?

For detailed insights on the major opportunities and strategies in the AI In Pharma market, request a sample here.

How does the AI In Pharma market relate to the overall economy and other similar markets?

For detailed insights on AI In Pharma's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the AI In Pharma industry?

For detailed insights on the mergers and acquisitions in the AI In Pharma industry, request a sample here.

What are the key dynamics influencing the AI In Pharma market growth? SWOT analysis of the AI In Pharma market.

For detailed insights on the key dynamics influencing the AI In Pharma market growth and SWOT analysis of the AI In Pharma industry, request a sample here.